Pilot Study to Examine the Use of Rivaroxaban After Angioplasty for Critical Limb Ischemia
Clinical trial NCT02260622 · COMPLETED
Trial details
- NCT number
- NCT02260622
- Sponsor
- Ottawa Hospital Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2017-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.